Impact of the World Trade Organization TRIPS Agreement on the pharmaceutical industry in Thailand

被引:0
|
作者
Supakankunti, S [1 ]
Janjaroen, WS
Tangphao, O
Ratanawijitrasin, S
Kraipornsak, P
Pradithavanij, P
机构
[1] Chulalongkorn Univ, Fac Econ, Ctr Hlth Econ, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Coll Publ Hlth, Bangkok 10330, Thailand
[3] Chulalongkorn Univ, Fac Med, Dept Pharmacol, Bangkok 10330, Thailand
[4] Chulalongkorn Univ, Fac Pharmaceut Sci, Bangkok 10330, Thailand
关键词
drug industry; commerce; drug costs; legislation; drug; patents; treaties; Thailand;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The 1994 World Trade Organization (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established minimum universal standards in all areas of intellectual property. It is intended to implement these standards globally through a WTO enforcement mechanism. The present article proposes a strategy for alleviating the potentially negative impact of TRIPS in Thailand in relation to the following: purchasers; prescribers and dispensers; producers; products; price control; patent-to-third-party; parallel imports; power of the customer; patentable new drugs; personnel; and prevention policies. The following TRIPS provisions are pertinent to the pharmaceutical industry in Thailand: the limited term of product and process patents; the conditions of protection; and the broad scope for compulsory licensing and enforcement procedures in the national patent system.
引用
收藏
页码:461 / 470
页数:10
相关论文
共 50 条